01 Rising Demand for Next-Generation Skin Boosters The increasing demand for next-generation skin boosters is driven by advancements in bio-revitalization technology, growing consumer awareness of long-term skin hydration, and the rising preference for non-invasive skin rejuvenation solutions. Technologies such as cross-linked hyaluronic acid, peptide-enriched formulas, and polydeoxyribonucleotide (PDRN)-based boosters are revolutionizing the market by enhancing collagen stimulation, extending hydration duration, and improving skin elasticity. For instance, in February 2025, Prollenium launched VAMP, a bio-revitalizing skin booster infused with PDRN, vitamins, amino acids, and minerals, designed to improve skin tonicity, hydration, and overall rejuvenation. The trend toward scientifically backed, next-generation skin rejuvenation solutions is fueling demand for cutting-edge anti-aging treatments, positioning skin boosters as a vital component in modern aesthetic dermatology. This growing inclination toward science-based formulations continues to drive market expansion and innovation.
02 Increasing Demand for Minimally Invasive Skin Booster The rising demand for minimally invasive skin boosters is largely attributed to consumer preferences for non-surgical procedures that improve skin health while offering minimal downtime. Likewise, increasing regulatory approvals for innovative treatments have boosted confidence in these procedures. For example, in May 2023, the FDA approved Skinvive by Juvéderm, a minimally invasive hyaluronic acid (HA) microdroplet injection aimed at improving cheek smoothness and skin hydration. A clinical trial revealed that after six months of treatment, 72% of patients experienced enhanced facial hydration, while 63% noticed improved radiance. As non-invasive procedures continue to evolve, the integration of stem cell-derived boosters and smart delivery systems is expected to further enhance hydration and elasticity, fostering continued market growth.
June 2026 Galderma expanded its aesthetic medicine portfolio with new clinical advancements and product development initiatives for injectable skin rejuvenation solutions, strengthening its position in the skin boosters and minimally invasive aesthetics market.
April 2026 Merz Aesthetics launched enhanced aesthetic treatment solutions under its Belotero® portfolio, expanding injectable skin revitalization options focused on hydration, skin quality, and natural-looking results.
December 2025 Teoxane expanded the global availability of its Teosyal® Redensity skin booster products through new market launches, supporting demand for injectable treatments targeting skin hydration and elasticity.
September 2025 IBSA Derma introduced new developments in its Profhilo® injectable skincare portfolio, expanding regenerative aesthetic solutions based on hyaluronic acid technology.